CRISTINA DOMINGUEZ: Open Payments
NPI 1720843824 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 23 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $144 · 2025 $537
Food & beverage: $537
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 11 | $251 |
| Novo Nordisk Inc | 4 | $144 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| Vifor Pharma, Inc. | 1 | $17 |
| SCPHARMACEUTICALS INC. | 1 | $15 |
Products named: Ozempic, Filspari, FARXIGA, Kerendia, Wegovy, Veltassa, FUROSCIX.
Industry payments across TX — which companies pay providers there.
